Radiopharm Theranostics Lists 384.5M New Shares on ASX
Radiopharm Theranostics Limited announced the quotation of 384,493,800 new ordinary fully paid shares on the Australian Securities Exchange (ASX) under the ticker RAD. These shares were issued on July 28, 2026, as part of a previously announced placement, with each share issued for AUD 0.015. The issuance also involved 1,281,646 American Depositary Shares (ADS) representing these underlying ordinary shares. Following this quotation, the total number of ordinary fully paid shares on issue will be 3,928,709,960.
Key Highlights
- 384,493,800 new ordinary fully paid shares quoted on ASX.
- Shares issued on July 28, 2026, at AUD 0.015 per share.
- 1,281,646 American Depositary Shares (ADS) issued, representing the new ordinary shares.
- Total ordinary fully paid shares on issue after quotation: 3,928,709,960.
- Further issues pending include 448.8M ordinary shares and options, and 1.3M ADR warrants.
Price Impact
More from RADX
Radiopharm Theranostics RAD101 Phase 3 Trial Set for 1Q27; RAD301 Data Positive
Radiopharm Theranostics Seeks Approval for $18.5M Capital Raise
Radiopharm Theranostics Reports Positive RAD 101 Phase 2b Results; Raises $12.5M
More in Corporate Action